Drug Profile
GS 930
Alternative Names: cHPMPC; cyclic cidofovir; cyclic HPMPC; cyclic-CDVLatest Information Update: 15 Mar 2010
Price :
$50
*
At a glance
- Originator Gilead Sciences
- Class Antivirals; Phosphonic acids; Small molecules
- Mechanism of Action DNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cytomegalovirus infections; Herpes simplex virus infections; HIV infections
Most Recent Events
- 22 Nov 1999 Suspended-I for Cytomegalovirus infections in USA (PO)
- 22 Nov 1999 Suspended-I for HIV infections treatment in USA (PO)
- 22 Nov 1999 Suspended-Preclinical for Herpes simplex virus infections in USA (PO)